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Abstract 
 
Background: The use of cyclophosphamide in cancer therapy is usually associated with challenging immunosuppression which exposes 
patients to increased risk of anemia and necessitating preventive measures during therapy. This study was carried out to investigate the 
efficacy of the hydro-ethanolic extract of the root of Z. zanthoxyloides in preventing and/or improving cyclophosphamide induced 
myelosuppression and oxidative stress in rats. 
Materials and Methods: Animals were divided into 6 groups of 6 rats each and were pretreated oral doses of 75, 150 and 225 mg/kg of 
the extract for 7 days and then co-administered with 2.5 mg/kg cyclophosphamide for 28 days. 
Results: The LD50 of the extract was found to be 1682.3 mg/kg. Phytochemical analysis of the plant extract showed the presence of 
tannins, saponins, alkaloids and flavonoids, glycosides, terpenoids and phenols. In the anti-oxidant enzyme assay, CAT was significantly 
(p < 0.05) increased for animals treated with 150 mg/kg+CP compared to 75 mg/kg+CP and 225 mg/kg+CP. GPx was significantly (p < 
0.01) increased in rats treated with 75 mg/kg+CP compared to 150 mg/kg+CP and control. SOD was significantly (p < 0.01) increased in 
rats treated with 75 mg/kg+CP compared to the control. WBC was significantly (p < 0.05) reduced for 225 mg/kg, 225 mg/kg+CP (p < 
0.001), 150 mg/kg+CP (p < 0.001), 75 mg/kg+CP (p < 0.001) and CP administered rats (p < 0.001) respectively compared to the control. 
LDL and CHOL were significantly reduced (p < 0.05) for rats treated with 75 mg/kg+CP, 225 mg/kg+CP and 225 mg/kg.  
Conclusion: Findings from this study demonstrates that the hydro-ethanolic root extract of Z. zanthoxyloides could be beneficial in 
hyperlipidemia and in cases of malignancies with abnormal cholesterol metabolism an effect which may be mediated via combating 
oxidative stress. 
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Introduction 
 
Many developing countries of the world are endowed with vast resources of natural products. This priceless heritage which 
includes medicinal plants have been used by people for centuries as drug substances for relief from illnesses, as health-care products, 
fragrances, flavors, sweeteners and as materials for pest control.  And today, plants appear to be the almost exclusive source of drugs for 
the majority of the world’s population, with  substances derived from higher plants constituting about a quarter of all prescribed 
medicines (Adesina, 2005).   
Zanthoxylum zanthhoxyloides is a component of the rainforest vegetation of Southern Nigeria, and is represented by eleven 
species.  A few of these species occur more abundantly in the savannah and dry forest vegetation of South-western Nigeria.  Throughout 
West Africa, the root, stem bark and leaves of Z. zanthoxyloides are commonly used in traditional medicine. They are considered 
antiseptic, analgesic and diaphoretic. Root or stem bark macerations, decoctions or infusions are widely taken to treat malaria, fever, 
sickle cell anemia, tuberculosis, paralysis, edema and general body weakness. Studies have also shown it to possess high antioxidant 
property (Andersson et al., 1996; Sofowora et al., 1975). Traditional healers throughout Nigeria have used species of the Zanthoxylum for 
the treatment of a wide range of disorders, including toothache, urinary and venereal diseases, rheumatism and lumbago. The plant is 
known for its anti-oxidative, anti-inflammatory, antisickling, antibacterial, antiviral, anti-hepatotoxicity, anti-allergic, anti-tumoral and 
antihypertensive properties (Adesina, 2005; Andersson et al., 1996; Sofowora et al., 1975). Hence, this study was carried out to 
determine the acute toxicity of the hydro-ethanolic root extract of Z. zanthoxyloides as well as its effect on serum biochemical markers, 
hematological and antioxidant indices in cyclophosphamide treated rats. 
 
Materials and Methods 
Plant Materials 
 
The fresh samples of roots of Z. zanthoxyloides used in the study were obtained commercially from Mushin market, Lagos  
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state, Nigeria. The plant was identified and authenticated in the Herbarium unit of the Department of Botany, University of Lagos, 
Akoka, Lagos state.  
 
Laboratory Animals 
 
Laboratory rats weighing between 120-130 g and mice weighing between 25-30 g of the male and female sex used in this study 
were obtained from the Laboratory Animal Centre, College of Medicine, University of Lagos, Lagos, Nigeria. The animals were kept 
under standard environmental conditions (23–25°C, 12 h/12 h light/dark cycle) and fed with standard rodent pellet (Livestock Feed PLC, 
Lagos, Nigeria) and water ad libitum. The experimental protocol adopted in this study was approved by the Experimentation Ethics 
Committee on Animal Use of the College of Medicine, University of Lagos, Lagos, Nigeria and was in accordance with the United States 
National Institutes of Health Guidelines for Care `and Use of Laboratory Animals in Biomedical Research (NIH, 1996).      
   
Extraction 
 
The roots were washed with clean water and air-dried for 7 days until constant weight was obtained. The dry root-bark was 
prepared by chopping the bark into small pieces and grinded with a laboratory mill into coarse powder. The powder was soaked with 10 
L of 96% ethanol and 4.29 L of distilled water for 72 h and then extracted.  The filtrate was then concentrated by drying in an oven at 40 
°C for 72 h. 
 
Acute Toxicity  
 
The acute toxicity study was carried out using 25 male albino mice. They were fasted for 12 h and administered the extract at 
doses of 1 - 5 g/kg orally. 
 
Preliminary Phytochemistry Analysis 
 
The hydroethanolic extract of Z. zanthoxyloides was screened for the following phytochemical principles; alkaloids, saponins, 
cardiac glycosides, anthraquinones,  tannins and  phlobatannins using simple established methods as outlined by Odebiyi and Sofowora 
(1978).  
 
Test Samples 
 
Weighed quantities of extracts were suspended in 3% v/v Tween 20 to prepare a suitable dosage form.  
 
Drugs 
 
Cycloxan® (Biochem–pharmaceutical  industries Ltd., Mumbai) containing 500 mg cyclosphosphamide was procured 
from the market and dilutions were made using sterile water for injection as mentioned on the label of the marketed product. 
 
Grouping 
 
Animals were randomly divided into six groups of six animals each, five experimental groups and one control group. Group 1 
served as the control and received 10mL/kg of 3% v/v Tween 20 for 28 days. Group II (Cyclophosphamide group) received 2.5 mg/kg of 
cyclophosphamide for 21 days. Groups III, IV and V were administered hydro-ethanolic extracts of the root of the plant at the doses of 75 
mg/kg, 150 mg/kg and 225 mg/kg (per oral) daily for 7 days followed by co-administration with cyclophosphamide for 21 days. Group VI was administered 
only 225 mg/kg of the extract for 28 days. 
After termination of oral treatments, blood samples were collected by retro orbital puncture for hematological and anti-oxidants 
study.  
 
Hematological Assessment 
 
Blood samples from experimental animals were collected into EDTA (ethylenediamine-tetraacetate) bottles and analysed using 
standard procedures. Erythrocyte (RBC), hemoglobin (Hb), packed cell volume (PCV), platelet count, and total and differential leukocyte 
(WBC), were determined using automated hematology analyzer. 
 
Measurement of In Vivo Antioxidants and MDA Levels 
 
The following antioxidant enzyme activities were determined using the spectrometer as follows: 
 
Determination of Superoxide Dismutase 
Superoxide Dismutase activity was determined by its ability to inhibit the auto-oxidation of epinephrine determined by the  
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increase in absorbance at 480nm as described by Sun and Zigma (1978). The reaction mixture (3ml) contained 2.95ml 0.05M sodium 
carbonate buffer pH 10.2, 0.02ml of tissue homogenate and 0.03ml of epinephrine in 0.005 N HCl was used to initiate the reaction. The 
reference cuvette contained 2.95ml buffer, 0.03ml of substrate (epinephrine) and 0.02ml of water. Enzyme activity was calculated by 
measuring the change in absorbance at 480nm for 5 minutes. 
 
Determination of Catalase Activity 
 
Serum catalase activity was determined according to the method of Beers and Sizer as described by Usoh et al. (2005) by  
measuring the decrease in absorbance at 240 nm due to the decomposition of H2O2 in a UV recording spectrophotometer. The reaction 
mixture (3 ml) contained 0.1ml of serum in phosphate buffer (50 mM, pH 7.0) and 2.9 ml of 30 mM H2O2 in phosphate buffer pH 7.0. An 
extinction coefficient for H2O2 at 240 nm of 40.0 M-1cm-1 (Aebi, 1984) was used for the calculation. The specific activity of catalase was 
expressed as moles of H2O2 reduced per minute per mg protein. 
 
Reduced Glutathione Determination 
 
The reduced glutathione (GSH) content of organ tissue as non-protein sulphydryls was estimated according to the method 
described by Sedlak and Lindsay (1968). To the homogenate 10% TCA was added, centrifuged. 1.0ml of supernatant was treated with 
0.5ml of Ellmans reagent (19.8mg of 5,5- dithiobisnitrobenzoic acid) (DTNB) in 100ml of 0.1% sodium nitrate) and 3.0ml of phosphate 
buffer (0.2M, pH 8.0). The absorbance was read at 412nm. 
 
Lipid Peroxidation 
 
Malondialdehyde (MDA) an index of lipid peroxidation was determined using the method of Buege and Aust (1978). 1.0ml of 
the supernatant was added to 2ml of (1:1:1) of TCA-TBA-HCl reagent (thiobarbituric acid 0.37%, 0.24N HCl and 15% TCA) 
tricarboxylic acid thiobarbituric acid-hydrochloric acid reagent was boiled at 100˚C for 15 min, and allowed to cool. Flocculent materials 
were removed by centrifuging at 3000 rpm for 10 min. The supernatant was removed and the absorbance read at 532nm against a blank. 
MDA was calculated using the molar extinction coefficient for MDATBA- complex of 1.56 × 105 M-1 cm-1.  
 
Statistical Analysis 
 
Results are expressed as mean ± SEM and differences between the groups were statistically determined by analysis of variance 
(ANOVA) followed by Tukey’s test using graph pad prism 6.0. p-values < 0.05 were considered as statistically signiﬁcant. 
 
Results 
Oral Acute Toxicity Study 
 
There was mortality at all doses; 20%, 60%, 60%, 80% and 100% mortality at 1, 2, 3, 4 and 5 g/kg respectively. (Table 1) 
 
 
Table 1: Probits and Percentage mortality in mice 
 
 
 
 
 
 
 
 
 
 
Preliminary Phytochemical Screening 
 
The preliminary phytochemical screening of the hydro-ethanolic root extract of Z. zanthoxyloides showed the presence of 
tannins, phlobatannins, saponins, cardiac glycosides, alkaloids, flavonoids, phenols and terpenoids. 
 
Effect of Hydro-Ethanolic Root Extract of Z. Zanthoxyloides on Hematological Parameters 
 
There was a significant (p ˂ 0.001) reduction in the WBC count of rats treated with 2.5 mg/kg CP (1.0±0.18), 75 mg/kg ZZ±CP 
(1.1±0.23), 150 mg/kg ZZ+CP and 225 mg/kg ZZ±CP (1.5±0.20) all compared to the control (7.2±0.96). All other hematological indices 
were not significantly different from the control.  
Extract Dose 
(mg/kg) 
Mortality %  Mortality Log Dose Probit 
1000 mg/kg 1 20 3.0 4.1 
2000 mg/kg 3 60 3.30 5.25 
3000 mg/kg  3 60 3.40 5.25 
4000 mg/kg 4 80 3.60 5.84 
5000 mg/kg 5 100 3.69 7.33 
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WBC count was significantly (p < 0.05) reduced in animals treated with 225 mg/kg ZZ only (3.80±1.40) compared to the 
control (7.2±0.96); a non-significant increase in WBC count in rats treated with 225 mg/kg ZZ only (3.80±1.40) compared to 75 mg/kg 
ZZ+CP (1.1±0.23), 150 mg/kg ZZ+CP (0.73±0.33) and 225 mg/kg ZZ+CP (1.5±0.20). (Table 2) 
 
Table 2: Effect of the hydro-ethanolic root extract of Z. zanthoxyloides on hematological parameters 
 
 
 
WBC   
 ×109/L 
MCV 
(gL) 
MCH        
(pg) 
MCHC 
(g/dL) 
HGB  
(g/dL) 
RBC 
×1012/L 
PCV (%) PLT (105/μL) 
   CONTROL 7.2±0.96 61.0±1.90 20.0±0.81 32.0±0.30 11.0±1.40 5.60±0.50 34.0±4.00 656.0±13.70 
    2.5  
mg/kg CP 
1.0±0.18c 56.0±2.10 19.0±0.60 34.0±0.23 11.0±0.81 5.60±0.42 31.0±2.40 505±132.00 
  75 mg/kg   
ZZ+CP 
1.1±0.23c 59.0±2.0 19.0±0.42 33.0±1.20 9.0±0.73 4.70±0.36 28.0±1.30 501.0±151.00 
 150 mg/kg 
ZZ+CP 
0.73±0.33c 57.0±1.10 19.0±0.35 33.0±0.71 11.0±0.35 5.90±0.13 34.0±0.38 503.0±172.00 
 225 mg/kg 3.8±1.40f 58.0±1.70 19.0±0.70 33.0±0.31 11.0±0.54 5.40±0.19 34.0±1.90 723.0±11.60 
      225 mg/kg   
ZZ+CP 
1.5±0.20d 57.0±1.50 20.0±0.33 35.0±0.76 11.0±0.20 6.0±0.49 31.0±0.95 604.0±108.00 
 
Values are expressed as mean ± SEM (n=5). * p ˂ 0.05, **** p ˂ 0.0001 versus control (One Way ANOVA followed by Tukey’s 
posthoc multiple comparison test). 
Effect of the hydro-ethanolic root extract of Z. zanthoxyloides on biochemical parameters I 
 
There was no statistically significant difference in the levels of all parameters assessed compared to the control (Table 3A). 
 
Table 3A: Effect of the hydro-ethanolic root extract of Z. zanthoxyloides on biochemical parameters  
 
 AST, IU      ALT, IU ALP, IU BIL-T, mg/dL CREA, mg/dL UREA, 
mg/dL 
ALB, g/L TP, g/dL 
CONTROL 29.33±2.91 26.00±3.06 41.00±1.15 0.53±0.12 1.10±0.06 43.67±1.67 2.30±0.17 19.33±14.83 
2.5 mg/kg 
CP 
35.33±2.03 23.00±3.51  31.67±5.46 0.53±0.07  1.13±0.07 40.00±4.51 3.17±0.16 5.73±0.48 
75 mg/kg 
ZZ+CP 
43.67±2.73 32.00±5.03 35.67±8.84 0.57±0.09 1.17±0.15 47.33±4.26 3.03±0.47 5.13±0.58 
150 mg/kg 
ZZ+CP 
25.33±4.10 31.00±5.03 40.00±5.57 0.47±0.07 0.83±0.03 34.00±2.08 3.23±0.27 5.27±0.58 
225 mg/kg 
ZZ 
35.67±3.57 22.67±3.18 37.00±4.58 0.47±0.03 0.97±0.03 41.33±6.39 3.17±0.33 4.67±0.26 
225 mg/kg 
ZZ+CP 
32.67±8.45 30.00±6.66 34.00±6.66 0.57±0.15 1.00±0.06 45.33±5.78 2.97±0.09 5.23±0.19 
 
 Values are expressed as mean±SEM (n=5). No significant difference from the control 
Effect of the hydro-ethanolic root extract of Z. zanthoxyloides on biochemical parameters II 
 
LDLc was significantly (p < 0.0001, 0.001) reduced at 75 mg/kg ZZ+CP (91.00±6.11), 225 mg/kg ZZ (95.34±4.19) and 225 
mg/kg ZZ+CP (92.00±5.13) compared to the control (128.67±2.60). There was significant (p < 0.05) reduction at 225 mg/kg ZZ 
(95.34±4.19), significant (p < 0.01) reduction at 225 mg/kg ZZ+CP (92.00±5.13) compared to 150 mg/kg ZZ+CP (117.00±9.17). CHOL 
was significantly (p < 0.0001) reduced at 75 mg/kg ZZ+CP (128.0±7.55), 225 mg/kg ZZ (134.33±12.44) and 225 mg/kg ZZ+CP 
(130.33±6.70) compared to the control (177.33±6.77). A nonsignificant reduction in triglycerides was seen at all doses used compared to 
CP administered and control rats. (Table 3B) 
 
Effect of hydro-ethanolic root extract of Z. zanthoxyloides on anti-oxidant enzymes 
 
SOD showed a significant (p ˂ 0.001) increase at 75 mg/kg ZZ+CP (2.90±0.21) when compared with the CP treated 
(1.20±0.32) rats, a significant (p ˂ 0.001) reduction at 150 mg/kg ZZ+CP (1.40±0.11), 225 mg/kg ZZ only (0.93±0.11) compared to rats 
treated with 75 mg/kg ZZ+CP (2.90±0.21). CAT levels at 150 mg/kg ZZ+CP (19.0±2.20) were significantly (p ˂ 0.05) increased 
compared to 75 mg/kg ZZ+CP (12.0±0.78). A significant (p < 0.05) increase was observed at 150 mg/kg ZZ+CP (19.0±2.20) compared 
to 75 mg/kg ZZ+CP (12.0±0.78), 225 mg/kg+CP (12.0±0.46). GPx levels was significantly (p ˂ 0.001) increased in rats treated with 75 
mg/kg ZZ+CP (0.89±0.058) compared to the control (0.49±0.046), and at p ˂ 0.01 for rats treated with 75mg/kg ZZ+CP (0.89±0.058) 
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compared to CP treated (0.36±0.095). There was significant (p ˂ 0.01) reduction at 150 mg/kg+CP (0.41±0.034), p ˂ 0.001 at 225 
mg/kg+CP (0.39±0.055) compared to 75 mg/kg+CP (0.89±0.058). 
The levels of MDA in rats treated with 225 mg/kg ZZ only (0.054±0.0026) was significantly (p ˂ 0.01) reduced compared to 
150 mg/kg+CP (0.12±0.013). (Table 4) 
 
Table 3B: Effect of the hydro-ethanolic extract of Z. zanthoxyloides on biochemical parameters II 
 HDLc, mg/dL LDLc, mg/dL            CHOL, mg/dL TG, mg/dL 
CONTROL 39.33 ± 4.41                  128.67 ± 2.60            177.33 ± 6.77  48.67 ± 7.80 
2.5 mg/kg CP 34.33 ± 2.85               93.33 ± 4.67c             136.67 ± 8.01c 44.33 ± 4.10 
75 mg/kg ZZ+CP 28.67 ± 1.33               91.00 ± 6.11c             128.00 ± 7.55c 40.67 ± 5.90 
150 mg/kg ZZ+CP 26.67 ± 2.40              117.00 ± 9.17b            151.67 ± 11.22e, a 39.33 ± 0.88 
225 mg/kg ZZ 31.33 ± 3.67              95.34 ± 4.19d, α            134.33 ± 12.44c 38.00 ± 1.16 
225 mg/kg ZZ+CP 31.00 ± 2.00             92.00 ± 5.13c, β            130.33 ± 6.70c, α 37.33 ± 3.71 
 
Values are expressed as Mean ± SEM (n=5). *** p < 0.001, **** p < 0.0001 versus control; a p < 0.05, b p < 0.01 vs. 75 mg/kg ZZ + 2.5 
mg/kg CP; α p < 0.05, β p < 0.01 versus 150 mg/kg ZZ + 2.5 mg/kg CP. (Two-way ANOVA followed by Tukey’s posthoc multiple 
comparison test). 
 
Table 4: Effect of the hydro-ethanolic root extract of Z. zanthoxyloides on the level of antioxidant enzymes 
 
 GSH (U/mg protein) SOD (U/mg protein) CAT (U/mg protein) MDA (U/mg protein) GPx (U/mg protein) 
CONTROL 0.23±0.09 1.60±0.15 11.0±1.40 0.02±0.00 0.49±0.05 
2.5 mg/kg CP 0.06±0.02 1.20±0.32 16.0±1.80 0.02±0.00 0.36±0.09d 
75 mg/kg ZZ+CP 0.21±0.05 2.90±0.21e, a 12.0±0.78f, a 0.04±0.02 0.89±0.06e, a 
150 mg/kg ZZ+CP 0.05±0.01 1.40±0.11d 19.0±2.20f 0.12±0.01c 0.41±0.03e 
225 mg/kg ZZ 0.19±0.04 0.93±0.11d 13.0±0.058 0.05±0.00 0.28±0.03c 
225 mg/kg ZZ+CP 0.11±0.06 1.30±0.18 12.0±0.46f, a 0.02±0.00e 
 
0.39±0.05d 
 
Values are expressed as Mean ± SEM (n=5) * p < 0.05 versus control, *a p < 0.05 vs 150 mg/kg+CP, **a p < 0.01 versus CP and control, 
** p < 0.01 versus 150 mg/kg+CP, 75 mg/kg+CP, *** p < 0.001 versus 75 mg/kg+CP, **** p < 0.0001 vs control, 225mg/kg (Two Way 
ANOVA followed by Tukey’s posthoc multiple comparison test) 
 
 
Discussion  
 
This study was carried out to evaluate the preventive or positive modulatory roles of hydroethanolic root extract of Z. 
zanthoxyloides against cyclophosphamide induced myelosuppression and oxidative stress.  
In the acute toxicity study, oral administration of the extract of Z. zanthoxyloides produced mortality at all doses. The LD50 of 
the extract was found to be 1698.2 mg/kg. As documented by the Hodge and Sterner scale of toxicity, this value showed that the extract 
of Z. zanthoxyloides is slightly toxic to rats. 
 The phytochemical analysis of the plant extract showed the presence of tannins, saponins, alkaloids and flavonoids, 
glycosides, terpenoids and phenols. The antioxidant and antilipoperoxidative properties of this extract could be attributed to its 
constituent flavonoids and other polyphenolics as these phytocomponents have been widely reported to possess antioxidant and anti-
lipoperoxidative activities (Roy et al., 2005; Yang et al., 2010).  
Hematological analysis following sub-acute oral administration of the hydro-ethanolic extract of Z. zanthoxyloides showed that 
there was significant reduction in the WBC count of rats treated with the extract and cyclophosphamide.  WBC’s which are produced in 
the bone marrow are an important part of the immune system and the body’s natural weapons to fight off infections. A low WBC count is 
often linked to problems with the bone marrow and the inability to make enough white blood cells. This suggests that the extract is 
unable to improve immune suppression in treated rats. Extract of Z. zanthoxyloides may play no positive modulatory role in 
cyclophosphamide induced low white blood cell counts probably due to the ability of cyclophosphamide to elicit its toxic effects by 
acting directly on rapidly dividing cells like white blood cells and direct DNA damage, hence the inability of the extract to play any 
beneficial roles. Ogunbolude et al. (2014) reported that Z. zanthoxyloides showed cytotoxic and genotoxic effects in vitro on human 
leukocyte at a concentration of 150µg/ml, hence suggesting the possibility of a combined toxic role of the extract and cyclophosphamide 
on white blood cells. 
The imbalance between antioxidant and pro-oxidant system is responsible for oxidative stress. The antioxidant system consists 
of enzymatic components comprising CAT, SOD, and non-enzymatic components containing GSH, vitamins A, C, E and other 
exogenous sources (Adekunle et al., 2012). Findings from this study showed a significant increase in CAT, SOD and GPx respectively. 
Majority of diseases are mainly linked to oxidative stress due to free radicals (Gutteridgde, 1995). Free radicals are fundamental to any 
biochemical process and represent an essential part of aerobic life and metabolism (Tiwari, 2001). The most common reactive oxygen 
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species (ROS) include superoxide (02) anion, hydrogen peroxide (H202), peroxyl (ROO-) radicals, and reactive hydroxyl (OH.) radicals. 
The nitrogen derived free radicals are nitric oxide (NO.) and peroxynitrite anion (ONOO.) (Lobo et al., 2010). ROS have been implicated 
in over a hundred of disease states which range from arthritis and connective tissue disorders to carcinogenesis, aging, physical injury, 
infection and acquired immunodeficiency syndrome (Joyce, 1987). In treatment of these diseases, antioxidant therapy has gained an 
immense importance. Antioxidants have been reported to prevent oxidative damage by free radical and ROS, and may prevent the 
occurrence of disease, cancer and aging. It can interfere with the oxidation process by reacting with free radicals, chelating, catalytic 
metals, and also by acting as oxygen scavengers (Buyukokuroglu et al., 2001; Shahidi and Wanasundara, 1992). The antioxidant 
potentials of the extract suggests its probable usefulness in exerting multiple biological effects including free radical scavenging abilities, 
anti-inflammatory and anti-carcinogenic  effects possibly due to the presence of flavonoids and phenolic compounds (Miller, 1996).  
The selenium-containing enzyme GPx protects cells against ROS. SOD and catalase are present in all oxygen-metabolizing cells and 
their function is to provide a defense against the potentially damaging reactivities of superoxide and hydrogen peroxide.  
Several studies indicates that cyclophosphamide has a pro-oxidant character and generation of oxidative stress after 
administration leads to decrease in the activities of antioxidant enzymes and increase in lipid peroxidation in liver, lung and serum of 
mice and rats (Perez et al., 1991; Barja de Quiroga et al., 1990; Patel and Block, 1985). The increased level of antioxidant enzymes 
demonstrates the oxidant scavenging potentials especially at low and moderate doses of the extract and thus could be beneficial in 
conditions requiring cyclophosphamide therapy.  
On assessment of serum biochemical markers, LDL and CHOL were significantly decreased compared to vehicle treated 
control. This is in agreement with findings by Oyewole et al. (2012) who found out that fresh leaves and stem bark extracts of Z. 
zanthoxyloides caused significant reduction in the concentrations of serum total cholesterol and LDL-cholesterol in rats administered. 
Cholesterol is essential for proper functioning of the cell membrane as well as being very essential for vitamin D and steroid hormone 
synthesis. It is transported by LDL and HDL and significant lowering of total cholesterol and rise in HDL-C is a very desirable 
biochemical state for prevention of atherosclerosis and ischaemic conditions (Schwenke and Carew, 1989; Luc and Fruchart, 1991). The 
significant reduction in LDL and CHOL could be ascribed to the presence of saponin which finds usage in conditions like 
hypercholesterolemia, hyperglycemia, antioxidant, anticancer, anti-inflammatory and weight loss (Mandal et al., 2005; Manjunatha, 
2006). Saponins are known anti-nutritional factors, which lower cholesterol by binding with cholesterol in the intestinal lumen, 
preventing its absorption and/or by binding with bile acids, causing a reduction in the enterohepatic circulation of bile acids and increase 
its fecal excretion (Nimenibo-uadia, 2003; Jamea et al., 2010; Rotimi et al., 2011). Increased bile acid excretion is offset by enhanced bile 
acid synthesis from cholesterol in the liver and consequent lowering of the plasma cholesterol (James et al., 2010). This suggests that the 
extract could be beneficial in hypercholesterolemia and cardiovascular conditions triggered by abnormal cholesterol metabolism, an 
effect which may be mediated through improvement of antioxidant indices. The link between free radicals and disease processes has led 
to considerable research to develop nontoxic drugs that can scavenge free radicals hence the antioxidant potentials of the extract may 
confer on it the potential of being a very useful candidate in malignant conditions requiring cyclophosphamide therapy and with 
comorbid abnormal cholesterol metabolism.  
 
Conclusion 
 
The result obtained in this study suggests that the hydro-ethanolic root extract of Z. zanthoxyloides may have positive 
modulatory roles against cyclophosphamide induced toxic effects probably due to induction of the antioxidant system. However, it was 
unable to combat and/or improve cyclophosphamide induced myelosuppression. 
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